GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm
Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year Business live – latest updates GSK’s new boss, Luke Miels, has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer (…)
Site référencé: The Guardian (Asia Pacific)
6333.jpg?width=140&quality=85&auto=format&fit=max&s=1c5791af850c3595c3c51e687836c7de, 6333.jpg?width=460&quality=85&auto=format&fit=max&s=b1033df807cae6ecbeb1c36b574c5541, 6333.jpg?width=700&quality=85&auto=format&fit=max&s=17cc2c6eff6986b11e3d2b3e1f5aba58
The Guardian (Asia Pacific)
Middle East crisis live : Lebanese officials says Israeli strikes on Tyre have killed at least eight people
9/06/2026
A cage-fighting arena is just what Trump’s White House lawn needed. I have a suggestion on how to use it | Marina Hyde
9/06/2026
At the NBA finals, the Very Important President showed his favorite sport is status
9/06/2026
World Cup 2026 visa chaos : from referee Omar Artan to Iranian officials – who is affected ?
9/06/2026
‘I was dazzled. I thought the walls would fall down’ : the oral history of DMZ, the label and club night that gave dubstep its soul
9/06/2026
Delays from new EU border system may not ‘stabilise’ for two years, official says
9/06/2026